Intuitive Surgical reported Q2 revenue of $2.89 billion and adjusted earnings of $2.80 per share, beating analyst estimates. However, shares fell 11% as US procedure growth slowed to 12% from 14% in Q1, attributed to deferred treatments and changes in insurance coverage. The company maintained its 2026 global procedure growth forecast at 13.5%-15.5%, expecting results near the midpoint, slightly below analyst expectations. Intuitive also reaffirmed its profit margin and expense outlook, with strong growth in system placements and cash reserves.
Intuitive Surgical reported strong Q2 earnings with adjusted EPS of $2.80, surpassing analyst expectations due to high demand for its da Vinci robotic surgical systems. Despite the positive results, the stock dropped 12% in premarket trading after th...
Intuitive Surgical reported strong Q2 2026 results, with EPS of $2.80 beating estimates by nearly 13% and revenue reaching $2.89 billion, surpassing forecasts. This marks the fourth consecutive quarter the company has exceeded earnings expectations, ...
Intuitive Surgical announced a 19% revenue increase to $2.89 billion in Q2 2026, driven by a 16% rise in worldwide procedures and higher system placements. The company placed 468 da Vinci surgical systems, including 246 da Vinci 5 models, and grew it...
Intuitive Surgical is scheduled to release its Q2 2026 earnings report, with analysts forecasting an EPS of $2.48 and revenue of $2.83 billion, up from $2.44 billion last year. The company is known for its da Vinci robotic surgical systems and has a ...
In Q2 2026, AMD's stock surged 182.4%, driven by growth in AI workloads linked to large language models. CrowdStrike also saw strong gains of 95.6% due to a positive shift in the AI investment narrative. Conversely, Netflix's stock declined after bea...
